Nu Skin Enterprises (NUS) Common Equity (2009 - 2026)

Nu Skin Enterprises (NUS) has 18 years of Common Equity data on file, last reported at $794.1 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 5.32% year-over-year to $794.1 million; the trailing twelve-month figure through Mar 2026 stood at $794.1 million (up 5.32% YoY), and the FY2025 full-year result was $805.2 million, up 23.61% from the prior year.
• Common Equity fell to $794.1 million in Q1 2026, from $805.2 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $941.0 million in Q2 2022 to a low of $1.0 million in Q2 2023.
• A 5-year average of $761.7 million and a median of $805.2 million in 2025 frame the typical range for Common Equity.
• Across the five-year window, Common Equity sank 99.89% in 2023 and jumped 68516.4% in 2024, its largest moves.
• Tracing NUS's Common Equity over 5 years: stood at $897.3 million in 2022, then slipped by 8.4% to $822.0 million in 2023, then decreased by 20.74% to $651.5 million in 2024, then climbed by 23.61% to $805.2 million in 2025, then decreased by 1.39% to $794.1 million in 2026.
• Business Quant data shows NUS's Common Equity at $794.1 million in Q1 2026, $805.2 million in Q4 2025, and $799.8 million in Q3 2025.